Papulex™ Isocorrexion

Papulex™ Isocorrexion offers intense moisturization while fighting blemishes. It reduces dryness and flaking, while helping remove blemishes and preventing their reappearance. Can also be used to help relieve skin discomfort associated with oral isotretinoin, although this should always be discussed first with a healthcare professional.

It contains Defenskin™, which reduces adhesion of blemish-causing bacteria to the skin, helping prevent blemishes from forming.1 Key ingredients also include Niacinamide, which reduces redness and blemishes while preventing their return.2,3 Finally, it contains Biophytosebum™4 and Shea butter for intensive skin moisturising.

For dry skin types.

Available in 50ml.

Key Ingredients

Defenskin™

Reduces bacterial adhesion to the skin, helping prevent new blemishes from forming.1 Defenskin™ proactively defends the skin, whilst supporting its natural microbiome.

Niacinamide

Anti-blemish and anti-red/brown marks. Niacinamide also regulates skin oiliness, minimises pores and improves skin barrier, all to help improve overall skin texture.2,3

Biophytosebum™ and Shea butter

Intensively moisturises the skin to restore suppleness (“cushion effect”). Chosen for its repairing, regenerating and soothing properties, Biophytosebum™ is bio-compatible with the skin, non-comedogenic, and leaves skin feeling velvety. It spreads easily and absorbs quickly for maximum comfort of use.4

Our Results*

79% Roundel

79% of users had less skin flaking**

100% Roundel

100% of users had fewer signs of skin irritation**

86% Roundel

86% felt their skin was more comfortable

86% Roundel

86% felt their skin was less tight

88% Roundel

88% felt the overall condition of their skin had improved

89% Roundel

89% felt that their skin was hydrated

*Results obtained in a study with 29 patients on oral isotretinoin, who were displaying cutaneous side effects, and having used Papulex™ Isocorrexion twice daily for 28 days.

** Results reported by dermatologists

How To Use

Apply every morning and evening. Non-photosensitising. Non-comedogenic.

Use the Papulex™ range of products as part of your skincare routine to help:

Cleanse and remove excess skin oil with Papulex™ Moussant

Clarify, tighten pores and regulate skin oil levels with Papulex™ Lotion

Control and dry out existing blemishes, then help remove them and prevent their return with Papulex™ Gel

Hydrate and fight blemishes with Papulex™ Oil-Free Cream (for oily skin) or Papulex™ Isocorrexion (for dry skin)

Our Full Product Range

Browse our other products here

Papulex™ Moussant

Our pore-cleansing anti-blemish foaming gel. Gently purifies the skin while regulating its oiliness. Helps remove blemishes and prevent their return.

View Product >

Papulex™ Lotion

Our pore-minimising anti-blemish toner. Designed to tighten pores and regulate skin oiliness, while fighting blemishes and helping prevent their reappearance.

View Product >

Papulex™ Gel

Our targeted blemish corrector. Dries out localised blemishes, which helps remove them and prevent their return. Also regulates oiliness of skin.

View Product >

Papulex™ Oil-Free Cream

Our anti-blemish hydrating skin moisturiser for oily skin. Hydrates with no oily effect and helps mattify the skin – while fighting blemishes and helping prevent their reoccurrence.

View Product >
1 Rougier – The inhibiting effect of an anti-adhesion gel on the adhesion of the bacterium Propionibacterium acnes to corneocytes in subjects with acne. Nouv. Dermatol. 2003; 22: 7-11

2 Matts PJ et al. A Review of the Range of Effects of Niacinamide in Human Skin. IFSCC Magazine – vol 5, no 4 / 2002

3 Berson et al: Niacinamide: A Topical Vitamin with Wide-Ranging Skin Appearance Benefits Ch. 10. Cosmeceuticals and Cosmetic Practice. 1st Edition by PK Farris. @2014 John Wiley & Sons Ltd

4 Biophytosebum® Manufacturer Brochure ENG and FR

5 CS Dermatologie . Evaluation of the cutaneous tolerability of a care product in subjects suffering from acne and on an oral isotretinoin medication. Paris. CS Dermatologie . 2008. 3 p. Report No.: 05E2728PH